Related references
Note: Only part of the references are listed.Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Alessandro Mantovani et al.
DIABETES CARE (2018)
Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential
Pierre Bedossa
LIVER INTERNATIONAL (2018)
The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases
Kamila Wojcik-Cichy et al.
CLINICAL AND EXPERIMENTAL HEPATOLOGY (2018)
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus A meta-analysis
Wenjie Dai et al.
MEDICINE (2017)
Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease
Gyuri Kim et al.
PLOS ONE (2017)
Portal Inflammation Is Independently Associated With Fibrosis and Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease
Jake P. Mann et al.
HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
Association between Body Mass Index, Waist-to-Height Ratio and Adiposity in Children: A Systematic Review and Meta-Analysis
Nerea Martin-Calvo et al.
NUTRIENTS (2016)
Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial
Claudia Della Corte et al.
PLOS ONE (2016)
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?
G. Targher et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future
Qi Tang et al.
DRUG DISCOVERIES AND THERAPEUTICS (2015)
Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease
Pierre Bedossa
HEPATOLOGY (2014)
A 360-degree overview of paediatric NAFLD: Recent insights
Valerio Nobili et al.
JOURNAL OF HEPATOLOGY (2013)
Osteoporosis in Chronic Liver Disease
Anitha Yadav et al.
NUTRITION IN CLINICAL PRACTICE (2013)
Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children
P. E. Pardee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents: Position Paper of the ESPGHAN Hepatology Committee
Pietro Vajro et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses
William F. Powell et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Bone Physiology, Disease and Treatment Towards Disease System Analysis in Osteoporosis
Teun M. Post et al.
CLINICAL PHARMACOKINETICS (2010)
A reference standard for the description of osteoporosis
John A. Kanis et al.
BONE (2008)
Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence
N Binkley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Reactive oxygen species mediate RANK signaling in osteoclasts
H Ha et al.
EXPERIMENTAL CELL RESEARCH (2004)
Share Paper
